216 related articles for article (PubMed ID: 29023267)
1. Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD.
Shouval DS; Konnikova L; Griffith AE; Wall SM; Biswas A; Werner L; Nunberg M; Kammermeier J; Goettel JA; Anand R; Chen H; Weiss B; Li J; Loizides A; Yerushalmi B; Yanagi T; Beier R; Conklin LS; Ebens CL; Santos FGMS; Sherlock M; Goldsmith JD; Kotlarz D; Glover SC; Shah N; Bousvaros A; Uhlig HH; Muise AM; Klein C; Snapper SB
Inflamm Bowel Dis; 2017 Nov; 23(11):1950-1961. PubMed ID: 29023267
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.
Shouval DS; Biswas A; Kang YH; Griffith AE; Konnikova L; Mascanfroni ID; Redhu NS; Frei SM; Field M; Doty AL; Goldsmith JD; Bhan AK; Loizides A; Weiss B; Yerushalmi B; Yanagi T; Lui X; Quintana FJ; Muise AM; Klein C; Horwitz BH; Glover SC; Bousvaros A; Snapper SB
Gastroenterology; 2016 Dec; 151(6):1100-1104. PubMed ID: 27693323
[TBL] [Abstract][Full Text] [Related]
3. Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD.
Werner L; Lee YN; Rechavi E; Lev A; Yerushalmi B; Ling G; Shah N; Uhlig HH; Weiss B; Somech R; Snapper SB; Shouval DS
Front Immunol; 2020; 11():109. PubMed ID: 32117262
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Characterization of Very Early-Onset Inflammatory Bowel Disease with Interleukin-10 Signaling Deficiency: Based on a Large Cohort Study.
Zheng C; Huang Y; Hu W; Shi J; Ye Z; Qian X; Huang Z; Xue A; Wang Y; Lu J; Tang Z; Wu J; Wang L; Peng K; Zhou Y; Miao S; Sun H
Inflamm Bowel Dis; 2019 Mar; 25(4):756-766. PubMed ID: 30212871
[TBL] [Abstract][Full Text] [Related]
5. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.
Begue B; Verdier J; Rieux-Laucat F; Goulet O; Morali A; Canioni D; Hugot JP; Daussy C; Verkarre V; Pigneur B; Fischer A; Klein C; Cerf-Bensussan N; Ruemmele FM
Am J Gastroenterol; 2011 Aug; 106(8):1544-55. PubMed ID: 21519361
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.
Shouval DS; Ouahed J; Biswas A; Goettel JA; Horwitz BH; Klein C; Muise AM; Snapper SB
Adv Immunol; 2014; 122():177-210. PubMed ID: 24507158
[TBL] [Abstract][Full Text] [Related]
7. The clinical, molecular, and therapeutic features of patients with IL10/IL10R deficiency: a systematic review.
Sharifinejad N; Zaki-Dizaji M; Sepahvandi R; Fayyaz F; Dos Santos Vilela MM; ElGhazali G; Abolhassani H; Ochs HD; Azizi G
Clin Exp Immunol; 2022 Jun; 208(3):281-291. PubMed ID: 35481870
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-6, IL-23 profile and Treg/Th17 peripheral cell populations in pediatric patients with inflammatory bowel disease.
Zhu XM; Shi YZ; Cheng M; Wang DF; Fan JF
Pharmazie; 2017 May; 72(5):283-287. PubMed ID: 29441874
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
[TBL] [Abstract][Full Text] [Related]
10. PIR-B Regulates CD4
Uddin J; Tomar S; Sharma A; Waggoner L; Ganesan V; Marella S; Yang Y; Noah T; Vanoni S; Patterson A; Zeng C; Foster PS; Newberry R; Bishu S; Kao JY; Rosen MJ; Denson L; King PD; Hoebe K; Divanovic S; Munitz A; Hogan SP
Cell Mol Gastroenterol Hepatol; 2021; 12(4):1479-1502. PubMed ID: 34242819
[TBL] [Abstract][Full Text] [Related]
11. Aberrant frequency of IL-10-producing B cells and its association with the balance of Treg/Th17 in children with inflammatory bowel disease.
Zhu XM; Huang YM; Fan JF; Shi YZ
Pharmazie; 2015 Oct; 70(10):656-60. PubMed ID: 26601422
[TBL] [Abstract][Full Text] [Related]
12. Genetic Deficiency and Biochemical Inhibition of ITK Affect Human Th17, Treg, and Innate Lymphoid Cells.
Eken A; Cansever M; Somekh I; Mizoguchi Y; Zietara N; Okus FZ; Erdem S; Canatan H; Akyol S; Ozcan A; Karakukcu M; Hollizeck S; Rohlfs M; Unal E; Klein C; Patiroglu T
J Clin Immunol; 2019 May; 39(4):391-400. PubMed ID: 31025232
[TBL] [Abstract][Full Text] [Related]
13. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
[TBL] [Abstract][Full Text] [Related]
14. Eos Is Redundant for Regulatory T Cell Function but Plays an Important Role in IL-2 and Th17 Production by CD4+ Conventional T Cells.
Rieder SA; Metidji A; Glass DD; Thornton AM; Ikeda T; Morgan BA; Shevach EM
J Immunol; 2015 Jul; 195(2):553-63. PubMed ID: 26062998
[TBL] [Abstract][Full Text] [Related]
15. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
16. The TLR9 Agonist Cobitolimod Induces IL10-Producing Wound Healing Macrophages and Regulatory T Cells in Ulcerative Colitis.
Schmitt H; Ulmschneider J; Billmeier U; Vieth M; Scarozza P; Sonnewald S; Reid S; Atreya I; Rath T; Zundler S; Langheinrich M; Schüttler J; Hartmann A; Winkler T; Admyre C; Knittel T; Dieterich Johansson C; Zargari A; Neurath MF; Atreya R
J Crohns Colitis; 2020 May; 14(4):508-524. PubMed ID: 31630153
[TBL] [Abstract][Full Text] [Related]
17. Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.
Hu Y; Wang X; Yu S; Hou Y; Ma D; Hou M
Expert Opin Ther Targets; 2015 Jun; 19(6):723-32. PubMed ID: 25976230
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
[TBL] [Abstract][Full Text] [Related]
19. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
20. The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease.
Yan JB; Luo MM; Chen ZY; He BH
J Immunol Res; 2020; 2020():8813558. PubMed ID: 33381606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
